...
首页> 外文期刊>Aquatic Toxicology >Negative impacts of the sea lice prophylactic emamectin benzoate on the survival of hatchery released salmon smolts in rivers
【24h】

Negative impacts of the sea lice prophylactic emamectin benzoate on the survival of hatchery released salmon smolts in rivers

机译:海洋虱子预防性蛋白苯甲酸盐对孵化场存活的负面影响释放河流中的鲑鱼熔渣

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Emamectin benzoate (EB) is a prophylactic pharmaceutical used to protect Atlantic salmon (Salmo salar) smolts migrating out of rivers and into the ocean against sea lice parasites. Randomized control trials comparing the marine survival of smolts treated with EB to a control group is used to calculate the fraction of marine mortality attributable to sea lice parasitism. However, it is assumed that there is no baseline difference in survival induced by the application of EB treatment. We used a combined laboratory and field study approach to investigate the potential impacts of EB treatment on behaviour and survival of hatchery-reared Atlantic salmon in western Norway. In aquaria experiments, EB-treated salmon smolts did not differ significantly in exploratory behaviour. Fish from treated groups responded similarly to simulated predator attack with spontaneous escape and elevated gill beat rate. Three rivers in the Osterfjord system of western Norway were selected for field experiments, Dale, Vosso, and Modalen. Dale River smolts were treated with intraperitoneal EB injections and had lower probability of detection in a wolf trap downstream of the release site than control smolts. Salmon smolts raised in the Vosso River hatchery were treated with EB delivered in their food and were detected on PIT antennas at the rivermouth of Vosso and Modalen at lower rates than control fish, but only when released at downstream sites. Calculation of risk ratios suggested that the bias in mortality caused by treatment with EB decreased the estimated survival of treated fish from an expected 18%to 46%, reducing the observable negative impact of sea lice on Atlantic salmon smolts in randomized control trials. The results suggest that estimates of the fraction of mortality attributable to sea lice may be underestimated due to lower baseline survival of treated fish caused by treatment and bring urgent attention towards a potential systematic underestimation of the impacts of sea lice on wild salmon.
机译:Emamectin Benzoate(EB)是一种用于保护大西洋鲑鱼(沙摩酱)散发出来的预防性药品,并进入海洋寄生虫。随机对照试验比较用EB对对照组治疗的泡沫的海洋存活率进行比较,用于计算归因于海洋虱寄生的海洋死亡率的一小部分。然而,假设EB治疗的应用诱导的存活中没有基线差异。我们利用了一个合并的实验室和现场研究方法来调查EB治疗对挪威西部孵化场饲养大西洋鲑鱼的行为和生存的潜在影响。在Aquaria实验中,EB处理的鲑鱼味道在探索行为中没有显着差异。来自治疗组的鱼类与模拟的捕食者攻击类似,自发逃逸和鳃率升高。选择挪威Osterfjord系统的三条河流被选为实际实验,戴尔,Vosso和Modalen。戴尔河斯莫尔茨被腹膜内EB注射治疗,并且在释放场地下游的狼蛛的检测概率低于控制液体。在Vosso河孵化场中饲养的鲑鱼斯普尔茨在食物中递送了EB,并在伏索和莫纳伦的岩石天线上被检测到较低的速率,而不是对照鱼,但只有在下游地点释放时。风险率的计算表明,EB治疗引起的死亡率偏差降低了预期的18%至46%治疗鱼类的存活率,降低了海虱对大西洋鲑鱼液体在随机对照试验中的可观察负面影响。结果表明,由于治疗鱼类治疗鱼的基线存活率降低了海洋虱子的死亡率分数估计,并提请紧急关注潜在的系统低估海虱对野生鲑鱼的影响。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号